Bridgeway Capital Management »

Aura Biosciences shares owned by Bridgeway Capital Management

Quarter-by-quarter ownership of Aura Biosciences (AURA) shares owned by Bridgeway Capital Management from 13F filings

Historical chart of Bridgeway Capital Management investment in Aura Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aura Biosciences held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aura Biosciences by Bridgeway Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $101k 16k 6.18
2025-06-30 $102k 16k 6.26

More positions owned by Bridgeway Capital Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Apple (AAPL)
Oracle Corporation (ORCL)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Wells Fargo & Company (WFC)
Palantir Technologies Cl A (PLTR)
Signet Jewelers SHS (SIG)
Amazon (AMZN)
Merck & Co (MRK)
Tutor Perini Corporation (TPC)
Verizon Communications (VZ)

View all positions for Bridgeway Capital Management

Top funds holding Aura Biosciences

Matrix Capital Management Company
Frazier Life Sciences Management
Adage Capital Partners GP
Long Focus Capital Management
Suvretta Capital Management
BlackRock
Medicxi Ventures Management
Vanguard Group
Franklin Resources
Nantahala Capital Management
Levin Capital Strategies
Geode Capital Management
UBS Group
State Street Corporation
Regency Capital Management

View all funds holding Aura Biosciences